MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Anzaldua SR et al. | Differential effects of 5 alpha-norethisterone on the histomorphology of the oviduct and uterus of the pregnant rabbit. | 1998 | Contraception | pmid:9673843 |
Powles TJ et al. | The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. | 1998 | Br. J. Cancer | pmid:9683306 |
Ostad SN et al. | In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments. | 1998 | J Control Release | pmid:9685884 |
Arteaga E et al. | In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women. | 1998 | Menopause | pmid:9689190 |
Picazo O et al. | A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats. | 1998 | Brain Res. | pmid:9689453 |
Bech P et al. | Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures. | 1998 Jul-Oct | Psychother Psychosom | pmid:9693354 |
Moyer DL and Felix JC | The effects of progesterone and progestins on endometrial proliferation. | 1998 | Contraception | pmid:9693400 |
Barkin JS and Ross BS | Medical therapy for chronic gastrointestinal bleeding of obscure origin. | 1998 | Am. J. Gastroenterol. | pmid:9707046 |
Kaba S et al. | Endometrial cytology in postmenopausal hormone replacement therapy. | 1998 | Diagn. Cytopathol. | pmid:9740987 |
Hammar M et al. | A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. | 1998 | Br J Obstet Gynaecol | pmid:9746385 |